Filing Details
- Accession Number:
- 0000899243-19-009014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-27 16:05:29
- Reporting Period:
- 2019-03-25
- Accepted Time:
- 2019-03-27 16:05:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1174940 | Oragenics Inc | OGEN | Pharmaceutical Preparations (2834) | 593410522 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1382225 | Fred Telling | 4902 Eisenhower Boulevard Tampa FL 33634 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-25 | 100,000 | $0.00 | 339,538 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series 1 Common Stock Warrants (right to buy) | Acquisiton | 2019-03-25 | 50,000 | $0.00 | 50,000 | $0.75 |
| Common Stock | Series 2 Common Stock Warrants (right to buy) | Acquisiton | 2019-03-25 | 50,000 | $0.00 | 50,000 | $0.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2019-03-25 | 2020-09-25 | No | 4 | P | Direct |
| 50,000 | 2019-03-25 | 2024-03-25 | No | 4 | P | Direct |
Footnotes
- Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units.
Billionaire Hedge Funds
